KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
KŠB Advises J&T Banka, UniCredit and PPF banka on the Next Phase of EMMA Capital’s Bond Programme
KŠB has continued its legal advisory role in connection with investment group EMMA Capital’s bond programme, which has been generating sustained and strong investor interest.
KŠB Shortlisted Again for the Chambers Europe Awards 2026
We are pleased to announce that, following our repeated recognition as Law Firm of the Year in the Czech Republic by the international ranking agency Chambers & Partners, Kocián Šolc Balaštík (KŠB) has once again been shortlisted for this prestigious distinction as part of the Chambers Europe Awards 2026.
KŠB "Scores" Major Infrastructure Win: The New Ball Sports Centre in České Budějovice
KŠB has advised on the execution of a construction contract for the Ball Sports Centre in České Budějovice, a major public infrastructure project set to become a new landmark for sport and community life in the region.
